Advate (Low Dose)
TDU16220
Phase 2 mab completed
Quick answer
Advate (Low Dose) for Hemophilia A is a Phase 2 program (mab) at Sanofi Pasteur with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sanofi Pasteur
- Indication
- Hemophilia A
- Phase
- Phase 2
- Modality
- mab
- Status
- completed